Cargando…
Inhibition of viral and bacterial trigger-stimulated prostaglandin E(2) by a throat lozenge containing flurbiprofen: An in vitro study using a human respiratory epithelial cell line
OBJECTIVES: Symptoms of sore throat result from oropharyngeal inflammation, for which prostaglandin E(2) is a key mediator. Flurbiprofen is a non-steroidal anti-inflammatory that provides sore throat relief. The preliminary objective of this study was to develop an in vitro model for assessing prost...
Autores principales: | Lambkin-Williams, Rob, Mann, Alex, Shephard, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522825/ https://www.ncbi.nlm.nih.gov/pubmed/33029351 http://dx.doi.org/10.1177/2050312120960568 |
Ejemplares similares
-
Improvements in throat function and qualities of sore throat from locally applied flurbiprofen 8.75 mg in spray or lozenge format: findings from a randomized trial of patients with upper respiratory tract infection in the Russian Federation
por: Burova, Natalia, et al.
Publicado: (2018) -
Bactericidal activity of hexylresorcinol lozenges against oropharyngeal organisms associated with acute sore throat
por: Matthews, Derek, et al.
Publicado: (2020) -
Virucidal action of sore throat lozenges against respiratory viruses parainfluenza type 3 and cytomegalovirus
por: Shephard, Adrian, et al.
Publicado: (2015) -
A multicentre, randomised, double-blind, single-dose study assessing the efficacy of AMC/DCBA Warm lozenge or AMC/DCBA Cool lozenge in the relief of acute sore throat
por: Wade, Alan G, et al.
Publicado: (2011) -
Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method
por: Turner, Rob, et al.
Publicado: (2021)